Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can 'Treatment Signals' stop aggression relapse in kids?

NCT ID NCT04045600

Knowledge-focused Sponsor: Rutgers, The State University of New Jersey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding visual signals and gradually introducing real-life materials can help children with severe aggression or self-injury maintain progress after communication training. The 24 participants, ages 3 to 17, will be observed in different settings to see if the improved training reduces relapse when routines change or caregivers are distracted.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (functional communication training with discriminative stimuli)
What this could lead to
If successful, this could lead to more durable treatments for severe behavior problems that work outside the clinic.
What could go wrong
This is a small, early-stage behavioral study with only 24 participants, so results may not apply broadly. The intervention is complex and may not translate easily to real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2021

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Boys and girls from ages 3 to 17 * Destructive behavior that occurs at least 10 times a day despite previous treatment * Destructive behavior reinforced by social consequences like attention (FCT is not appropriate for automatically reinforced destructive behavior) * On a stable psychoactive drug regimen for at least 10 half-lives per drug or drug free * Stable educational plan and placement with no anticipated changes during the child's treatment Exclusion Criteria: * Patients who do not meet the inclusion criteria * Patients currently receiving 15 or more hours per week of treatment for their destructive behavior * DSM-5 diagnosis of Rett syndrome or other degenerative conditions (e.g., inborn error of metabolism) * A comorbid health condition or major mental disorder that would interfere with study participation * Occurrence of SIB during study assessments that presents a risk of serious or permanent harm (e.g., detached retinas) based on our routine clinical-risk assessment * Patients requiring drug-treatment changes, but the experimenters will invite these patients to participate if they meet inclusion criteria after drug regimen is stable.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aggression are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Aggression Self-Injurious Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aggression Self-injurious behavior

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Children's Specialized Hospital - Rutgers University Center for Autism Research, Education, and Services

    RECRUITING

    Somerset, New Jersey, 00873, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.